Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Cancer. 2015 Feb 11;121(11):1800–1808. doi: 10.1002/cncr.29290

Table 1.

First-line management strategies, by age category.

Age 66–80 years
N (%)
Age >80 years
N (%)
χ2
p-value
Observation 403 (11.6) 300 (26.0) <0.0001
CVP 30 (0.9) 23 (2.0)
R-CVP 169 (4.9) 165 (14.3)
CHOP 296 (8.5) 73 (6.3)
R-CHOP 2,581 (74.2) 595 (51.5)

Note: CVP=cyclophosphamide, vincristine, prednisone; R-CVP=rituximab + CVP; CHOP=cyclophosphamide, doxorubicin, vincristine, prednisone; R-CHOP=rituximab + CHOP

Note: percentages may not add up to 100.0% due to rounding.